The pathogenesis of osteoarthritis involves bone, cartilage and synovial inflammation: may estrogen be a magic bullet?

Karsdal, M. A.; Bay-Jensen, A. C.; Henriksen, K.; Christiansen, C.
December 2012
Menopause International;Dec2012, Vol. 18 Issue 4, p139
Academic Journal
The female predominance of polyarticular osteoarthritis (OA), and in particular the marked increase of OA in women after the menopause points to a likely involvement of female sex hormones in the maintenance of cartilage homeostasis. This perception has inspired many research groups to investigate the role of estrogens in the modulation of cartilage homeostasis with the ultimate aim to clarify whether estrogen replacement therapy (ERT) could provide benefits in preventing the rapid rise in the prevalence of OA in postmenopausal women. The effects of ERT and selective estrogen-receptor modulators on the joint in various experimental models have been investigated. Clinically, the effects of estrogens have been evaluated by post hoc analysis in clinical trials using biochemical markers of cartilage and bone degradation. Lastly, the Women's Health Initiative trial (WHI) investigated the effects of estrogens on the joint and joint replacements. Even though the exact mode of action still needs to be elucidated, the effect involves both direct and indirect mechanisms on the whole joint pathophysiology. Several animal models have demonstrated structural benefits of estrogens, as well as significant effects on joint inflammation. This is in complete alignment with clinical data using biochemical markers of joint degradation which demonstrated approximately 50% inhibition of cartilage destruction. These finding were recently validated in WHI, where women taking estrogens had significantly less joint replacement. In conclusion, the pleiotropic effect of estrogens on several different tissues may match the complicated aetiology of OA in some important aspects.


Related Articles

  • Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis. Eseonu, Onyedikachi I.; De Bari, Cosimo // Rheumatology;Feb2015, Vol. 54 Issue 2, p210 

    Mesenchymal stem cells (MSCs) are multipotent cells with the capacity to undergo chondrogenic differentiation. Systemically administered MSCs have been shown to preferentially accumulate at sites of tissue damage and inflammation, thus MSC-based therapy holds great promise for the treatment of...

  • Effects of diacerein on cartilage and subchondral bone in early stages of osteoarthritis in a rabbit model. Permuy, María; Guede, David; López-Peña, Mónica; Muñoz, Fernando; Caeiro, Jose-Ramón; González-Cantalapiedra, Antonio // BMC Veterinary Research;Jul2015, Vol. 11 Issue 1, p1 

    Background: Osteoarthritis is thought to be the most prevalent chronic and disabling joint disease in animals and humans. At present, there is no ideal treatment option. The aim of this study was to assess the effects of the treatment with oral diacerein on articular cartilage, synovial membrane...

  • Synovial shelves of the knee: association with chondral lesions. Christoforakis, Joseph; Sanchez-Ballester, Jordi; Hunt, Neil; Thomas, Rhidian; Strachan, Robin; Christoforakis, Joseph J; Strachan, Robin K // Knee Surgery, Sports Traumatology, Arthroscopy;Dec2006, Vol. 14 Issue 12, p1292 

    The objectives of the present study were to evaluate whether synovial shelves of the knee are associated with increased incidence of chondral lesions and to determine which types of plica are associated with significant articular damage. Data were collected prospectively from 1,000 consecutive...

  • Effectiveness of Glucosamine and Chondroitin Sulfate Combination in Patients with Primary Osteoarthritis. Irsay, Laszlo; Borda, Monica Ileana; Nitu, Andreea Diana; Ciortea, Viorela; Onac, Ioan; Ungur, Rodica // Applied Medical Informatics;Dec2010, Vol. 27 Issue 4, p47 

    Purpose: Studying the effectiveness of chondroprotective agents for patients with primary knee arthritis or primary generalized osteoarthritis, according to the American College of Rheumatology 2000 criteria. Material and Methods: comparative study, the groups were constituted out of 25 patients...

  • Treatment Options for Degenerative Joint Disease of the Knee.  // Athletic Training & Sports Health Care: The Journal for the Prac;May/Jun2011, Vol. 3 Issue 3, p131 

    The article offers information on the various treatment options available in the U.S. for osteoarthritis of the knee. It focuses on hyaluronic acid viscosupplementation, its indications for present use, and its future scope. Osteoarthritis is characterized by the degeneration of articular...

  • Chondroprotective effect of high-molecular-weight hyaluronic acid on osteoarthritic chondrocytes in a co-cultivation inflammation model with M1 macrophages. Bauer, Christoph; Niculescu-Morzsa, Eugenia; Jeyakumar, Vivek; Kern, Daniela; Späth, Stephan S.; Nehrer, Stefan // Journal of Inflammation;9/13/2016, Vol. 13, p1 

    Background: Osteoarthritis (OA) is described by an imbalance between anabolic and catabolic processes in the affected joint. This dysregulation of metabolism affects not only chondrocytes within cartilage tissue but also the cells of the synovial membrane across the border of the joint. An...

  • Osteoarthritis. Samuels, Jonathan; Krasnokutsky, Svetlana; Abramson, Steven B. // Bulletin of the NYU Hospital for Joint Diseases;2008, Vol. 66 Issue 3, p244 

    While research in osteoarthritis has focused on the events that lead to the destruction of articular cartilage, recent evidence suggests that two other components of the joints--bone and synovium--also play key roles in pathogenesis. All three tissues undergo alterations in concert at the...

  • Effects of estrogen on the proliferation and differentiation of human embryo mandibular condylar chondrocytes. Pang Leih; Zhang Yuerong; Liu Zhonglin // West China Journal of Stomatology;Dec2013, Vol. 31 Issue 6, p628 

    Objective To determine the effects of different estrogen concentrations on the proliferation and differentiation of human embryo mandibular condylar chondrocytes (MCCs). Methods In w'fro-cultured MCCs were incubated and treated with estrogen at different concentrations. The MCCs were identified...

  • Treatment Options for Initial Maintenance Therapy of Persistent Asthma: a Review of Inhaled Corticosteroids and Leukotriene Receptor Antagonists. Creticos, Peter S. // Drugs;2003 Supplement 2, Vol. 63 Issue 21, p1 

    Inhaled corticosteroids (ICSs) are recognized as the cornerstone of asthma therapy. They are considered to be the most effective anti-inflammatory medication currently available for the treatment of persistent asthma, regardless of its severity. Leukotriene receptor antagonists (LTRAs) are also...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics